GRIFOLS | GRF - Nettoeinkommen

Aktienkurs
8.96
Täglich Wechseln
0.14 1.63%
Monatlich
0.04%
Jährlich
5.07%
Q2 Prognose
8.72




Nettoeinkommen Veränderung Datum
Alcon AG USD 217M 20M 2025-12
Almirall EUR 19.58M 7M 2025-12
Amadeus IT EUR 247.5M 113.3M 2025-12
Amarin USD -1.22M 6.51M 2025-12
argenx SE USD 532.95M 188.69M 2025-12
AstraZeneca USD 3.08B 754M 2026-03
Bayer EUR -3.76B 2.79B 2025-12
Cie Automotive EUR 149.91M 35.97M 2025-12
Demant DKK 427M 690M 2025-12
Ence Energia y Celulosa EUR -32.46M 17.36M 2025-12
Essilor EUR 928M 459M 2025-12
Ferrovial EUR 348M 192M 2025-12
Fresenius EUR 361M 17M 2025-12
Fresenius Medical Care EUR 327M 52.2M 2025-12
Galapagos EUR 782.15M 984.26M 2025-12
Genmab DKK 31M 370M 2025-12
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
GRIFOLS EUR 98.25M 28.72M 2025-12
Hikma Pharmaceutical USD 164M 45M 2025-12
Inditex EUR 1.6B 233M 2025-12
Merck EUR 319M 583M 2025-12
Novartis USD 3.16B 747M 2026-03
Philips EUR 395M 211M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR 1.61B 2.42B 2026-03
Smith & Nephew USD 293M 79M 2025-12
UCB EUR 1.08B 608M 2025-12
Viscofan EUR 33.67M 17.61M 2026-03